Structural basis for EGF receptor inhibition by the therapeutic antibody IMC-11F8.
Li, S., Kussie, P., Ferguson, K.M.(2008) Structure 16: 216-227
- PubMed: 18275813 
- DOI: 10.1016/j.str.2007.11.009
- Primary Citation of Related Structures:  
3B2U, 3B2V - PubMed Abstract: 
Therapeutic anticancer strategies that target and inactivate the epidermal growth factor receptor (EGFR) are under intense study in the clinic. Here we describe the mechanism of EGFR inhibition by an antibody drug IMC-11F8. IMC-11F8 is a fully human antibody that has similar antitumor potency as the chimeric cetuximab/Erbitux and might represent a safer therapeutic alternative ...